- Home
- Publications
- Publication Search
- Publication Details
Title
Creation of a long-acting nanoformulated dolutegravir
Authors
Keywords
-
Journal
Nature Communications
Volume 9, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-01-25
DOI
10.1038/s41467-018-02885-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Creation of a nanoformulated cabotegravir prodrug with improved antiretroviral profiles
- (2018) Tian Zhou et al. BIOMATERIALS
- Multimodal Theranostic Nanoformulations Permit Magnetic Resonance Bioimaging of Antiretroviral Drug Particle Tissue-Cell Biodistribution
- (2018) Bhavesh D. Kevadiya et al. Theranostics
- Long-acting slow effective release antiretroviral therapy
- (2017) Benson Edagwa et al. Expert Opinion on Drug Delivery
- Creation of a Long-Acting Nanoformulated 2′,3′-Dideoxy-3′-Thiacytidine
- (2017) Dongwei Guo et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Monotherapy with either dolutegravir or raltegravir fails to durably suppress HIV viraemia in humanized mice
- (2017) Alonso Heredia et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Autophagy facilitates macrophage depots of sustained-release nanoformulated antiretroviral drugs
- (2017) Divya Prakash Gnanadhas et al. JOURNAL OF CLINICAL INVESTIGATION
- The cursed duet today: Tuberculosis and HIV-coinfection
- (2017) Simon Tiberi et al. PRESSE MEDICALE
- A mature macrophage is a principal HIV-1 cellular reservoir in humanized mice after treatment with long acting antiretroviral therapy
- (2017) Mariluz Araínga et al. Retrovirology
- Comparison of the Local Tolerability to 5 Long-acting Drug Nanosuspensions with Different Stabilizing Excipients, Following a Single Intramuscular Administration in the Rat
- (2017) Ronnie Chamanza et al. TOXICOLOGIC PATHOLOGY
- Long-Acting Antiretrovirals: Where Are We now?
- (2017) Amesika N Nyaku et al. Current HIV/AIDS Reports
- Dolutegravir as maintenance monotherapy for HIV (DOMONO): a phase 2, randomised non-inferiority trial
- (2017) Ingeborg Wijting et al. Lancet HIV
- Acquisition of wild-type HIV-1 infection in a patient on pre-exposure prophylaxis with high intracellular concentrations of tenofovir diphosphate: a case report
- (2017) Elske Hoornenborg et al. Lancet HIV
- Safety and tolerability of long-acting cabotegravir injections in HIV-uninfected men (ECLAIR): a multicentre, double-blind, randomised, placebo-controlled, phase 2a trial
- (2017) Martin Markowitz et al. Lancet HIV
- Might dolutegravir be part of a functional cure for HIV?
- (2016) Mark A. Wainberg et al. CANADIAN JOURNAL OF MICROBIOLOGY
- Nanodrug formulations to enhance HIV drug exposure in lymphoid tissues and cells: clinical significance and potential impact on treatment and eradication of HIV/AIDS
- (2016) Jingwei Shao et al. Nanomedicine
- Development and characterization of a long-acting nanoformulated abacavir prodrug
- (2016) Dhirender Singh et al. Nanomedicine
- Microneedles: A New Frontier in Nanomedicine Delivery
- (2016) Eneko Larrañeta et al. PHARMACEUTICAL RESEARCH
- The promise and pitfalls of long-acting injectable agents for HIV prevention
- (2016) Raphael J. Landovitz et al. Current Opinion in HIV and AIDS
- HIV-1 cellular and tissue replication patterns in infected humanized mice
- (2016) Mariluz Araínga et al. Scientific Reports
- Drug Delivery Approaches in Addressing Clinical Pharmacology-Related Issues: Opportunities and Challenges
- (2015) Hong Wen et al. AAPS Journal
- Anti-HIV Drug-Combination Nanoparticles Enhance Plasma Drug Exposure Duration as Well as Triple-Drug Combination Levels in Cells Within Lymph Nodes and Blood in Primates
- (2015) Jennifer P. Freeling et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Pharmacokinetics of Long-Acting Tenofovir Alafenamide (GS-7340) Subdermal Implant for HIV Prophylaxis
- (2015) Manjula Gunawardana et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacodynamics of long-acting folic acid-receptor targeted ritonavir-boosted atazanavir nanoformulations
- (2015) Pavan Puligujja et al. BIOMATERIALS
- Prodrug and conjugate drug delivery strategies for improving HIV/AIDS therapy
- (2015) M.S. Palombo et al. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
- Cellular Responses and Tissue Depots for Nanoformulated Antiretroviral Therapy
- (2015) Andrea L. Martinez-Skinner et al. PLoS One
- A safety and pharmacokinetic trial assessing delivery of dapivirine from a vaginal ring in healthy women
- (2014) Annalene Nel et al. AIDS
- Pharmacokinetics of Injectable, Long-Acting Nevirapine for HIV Prophylaxis in Breastfeeding Infants
- (2014) John M. Cortez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- An overview of clinical and commercial impact of drug delivery systems
- (2014) Aaron C. Anselmo et al. JOURNAL OF CONTROLLED RELEASE
- Endosomal Trafficking of Nanoformulated Antiretroviral Therapy Facilitates Drug Particle Carriage and HIV Clearance
- (2014) D. Guo et al. JOURNAL OF VIROLOGY
- Long-acting HIV drugs advanced to overcome adherence challenge
- (2014) Elie Dolgin NATURE MEDICINE
- Preclinical Pharmacokinetics and Tissue Distribution of Long-Acting Nanoformulated Antiretroviral Therapy
- (2013) Nagsen Gautam et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Long-acting injectable formulations of antipsychotic drugs for the treatment of schizophrenia
- (2013) Eun Ji Park et al. ARCHIVES OF PHARMACAL RESEARCH
- Common AIDS-associated opportunistic infections
- (2013) E. Ong CLINICAL MEDICINE
- Chemistry-enabled drug delivery (prodrugs): recent progress and challenges
- (2013) Sophie-Dorothee Clas et al. DRUG DISCOVERY TODAY
- Functional Proteome of Macrophage Carried Nanoformulated Antiretroviral Therapy Demonstrates Enhanced Particle Carrying Capacity
- (2013) Andrea L. Martinez-Skinner et al. JOURNAL OF PROTEOME RESEARCH
- Long-acting parenteral nanoformulated antiretroviral therapy: interest and attitudes of HIV-infected patients
- (2013) Jennifer Williams et al. Nanomedicine
- Pharmacodynamic and Antiretroviral Activities of Combination Nanoformulated Antiretrovirals in HIV-1–Infected Human Peripheral Blood Lymphocyte–Reconstituted Mice
- (2012) Upal Roy et al. JOURNAL OF INFECTIOUS DISEASES
- New generation humanized mice for virus research: Comparative aspects and future prospects
- (2012) Ramesh Akkina VIROLOGY
- Cell-mediated drug delivery
- (2011) Elena V Batrakova et al. Expert Opinion on Drug Delivery
- Macrophage endocytic trafficking of antiretroviral nanoparticles
- (2011) Irena Kadiu et al. Nanomedicine
- In VitroAntiretroviral Properties of S/GSK1349572, a Next-Generation HIV Integrase Inhibitor
- (2010) Masanori Kobayashi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- CD8+ Cell Depletion Accelerates HIV-1 Immunopathology in Humanized Mice
- (2010) S. Gorantla et al. JOURNAL OF IMMUNOLOGY
- Nanoformulated Antiretroviral Drug Combinations Extend Drug Release and Antiretroviral Responses in HIV-1-Infected Macrophages: Implications for NeuroAIDS Therapeutics
- (2010) Ari S. Nowacek et al. Journal of Neuroimmune Pharmacology
- Macrophages Recognize Size and Shape of Their Targets
- (2010) Nishit Doshi et al. PLoS One
- Host hindrance to HIV-1 replication in monocytes and macrophages
- (2010) Anna Bergamaschi et al. Retrovirology
- Current status and challenges of antiretroviral research and therapy
- (2009) José A. Esté et al. ANTIVIRAL RESEARCH
- Successes, challenges, and limitations of current antiretroviral therapy in low-income and middle-income countries
- (2009) John A Bartlett et al. LANCET INFECTIOUS DISEASES
- NanoART synthesis, characterization, uptake, release and toxicology for human monocyte–macrophage drug delivery
- (2009) Ari S Nowacek et al. Nanomedicine
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More